Last reviewed · How we verify
Nebulized Magnesium Sulfate
Nebulized Magnesium Sulfate, marketed by Hospital General Naval de Alta Especialidad - Escuela Medico Naval, holds a unique position in the respiratory therapy segment. The drug's key strength lies in its key composition patent, which is set to expire in 2028, providing a period of exclusive market protection. The primary risk is the lack of clear revenue data and key trial results, which may limit investor confidence and market adoption.
At a glance
| Generic name | Nebulized Magnesium Sulfate |
|---|---|
| Also known as | MgSO4, Inhaled magnesium sulfate, Nebulized MgSO4, magnesium heptahydrate |
| Sponsor | Hospital General Naval de Alta Especialidad - Escuela Medico Naval |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison of Nebulized Ketamine With Nebulized Magnesium Sulfate for the Prevention of Postoperative Sore Throat (NA)
- Effect of Nebulized Magnesium Sulfate on Post-intubation Stress Response in Patients Undergoing Laparoscopic Cholecystectomy (NA)
- Treatment of Persistent Pulmonary Hypertension in Neonates With Nebulized Magnesium Sulfate (PHASE2, PHASE3)
- Nebulized Magnesium Sulfate and Sildenafil for Persistent Pulmonary Hypertension of Newborn (PHASE1, PHASE2)
- Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial. (PHASE3)
- Nebulized Versus Intravenous Magnesium Sulfate in Treatment of Asthma Exacerbation
- Different Doses of Nebulized Magnesium Sulphate in Status Asthmaticus (PHASE1)
- NiPPV in the Treatment of Acute Asthma Exacerbations (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: